Mucins Secreted by a Transformed Cell Line Derived from Human Tracheal Gland Cells
Overview
Authors
Affiliations
High-molecular-mass glycoconjugates are secreted by the continuous cell line MM-39, which has been obtained from cultured human tracheal gland cells transformed by simian virus 40. They were purified on Sepharose(R) CL-4B and then by two steps of density-gradient centrifugation. High-molecular-mass glycoproteins resistant to digestion by hyaluronidase, chondroitin ABC lyase and heparitinase were obtained, in addition to hyaluronic acid and proteoglycans. They were susceptible to beta-elimination. They contained polylactosaminoglycan chains as well as carbohydrate chains with a terminal sialic acid in the NeuAc alpha2-3 sequence. Most of them have a buoyant density of 1.45 g/ml in CsCl-density-gradient centrifugation, except for MUC1. The MM-39 cells were also characterized by a high expression of MUC1 and MUC4 genes, but they did not express MUC2, MUC3, MUC5B and MUC5AC. Therefore the MM-39 cells synthesized mucin-like glycoproteins as well as lysozyme and mucous proteinase inhibitor [Merten, Kammouni, Renaud, Birg, Mattéi and Figarella (1996) Am. J. Respir. Cell. Mol. Biol. 15, 520-528]; they should be considered as having a mixed, both serous and mucous, phenotype.
The battle between influenza and the innate immune response in the human respiratory tract.
Nicholls J Infect Chemother. 2013; 45(1):11-21.
PMID: 24265946 PMC: 3780943. DOI: 10.3947/ic.2013.45.1.11.
Acquired cilia dysfunction in chronic rhinosinusitis.
Gudis D, Zhao K, Cohen N Am J Rhinol Allergy. 2012; 26(1):1-6.
PMID: 22391065 PMC: 3906518. DOI: 10.2500/ajra.2012.26.3716.
Lamblin G, Degroote S, Perini J, Delmotte P, Scharfman A, DAVRIL M Glycoconj J. 2002; 18(9):661-84.
PMID: 12386453 DOI: 10.1023/a:1020867221861.
Delmotte P, Degroote S, Merten M, Van Seuningen I, Bernigaud A, FIGARELLA C Glycoconj J. 2002; 18(6):487-97.
PMID: 12084984 DOI: 10.1023/a:1016038219183.
Mucus clearance as a primary innate defense mechanism for mammalian airways.
Knowles M, Boucher R J Clin Invest. 2002; 109(5):571-7.
PMID: 11877463 PMC: 150901. DOI: 10.1172/JCI15217.